All companies
Visit website
FloSpine
OperatingFloSpine Holdings, Inc.
Healthcare · Founded 2022
Applying new technology and design concepts to solve medical problems for human spinal column
Post-money valuation ⓘ
$47.6M
As of Feb 2023 · from FloSpine Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$81,644
Across 1 round since 2022
Latest share price
$2.90
FloSpine Common Stock 1 offering price
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its source$1.3M
−$166K
2020
$1.6M
−$700K
2021
$2.0M
−$475K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
Income statement
Revenue
$1,254,783
$1,557,981
$2,020,171
Cost of goods sold
$280,235
$470,571
$530,698
Gross margin
78%
70%
74%
Net income
-$166,166
-$699,753
-$474,585
Taxes paid
$0
$0
$0
Balance sheet
Cash
$68,182
$855,057
$281,341
Accounts receivable
$212,113
$160,731
$326,283
Total assets
$1,228,098
$2,164,439
$1,912,054
Short-term debt
$176,552
$1,774
$45,575
Long-term debt
$229,998
$1,962,359
$2,012,231
Total liabilities
$406,550
$1,964,133
$2,057,806
Other
Headcount
—
7
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$47.6M
post-money
FloSpine Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $81.6K / $1.1MInvestors 165Post-money $47.6M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
165 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001948394Share price $2.90
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.